SUZANNE BUSHONG: Open Payments
NPI 1417929316 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$448 in 16 payments from 8 companies in 2025. Trend: 2023 $361 · 2024 $378 · 2025 $448
Food & beverage: $448
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $180 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| Tonix Medicines, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
| Acella Pharmaceuticals, LLC | 1 | $14 |
Products named: VRAYLAR, AIRSUPRA, CAPLYTA, TONMYA, Auvelity, KEVEYIS, Wegovy, NP Thyroid 60.
Industry payments across AR — which companies pay providers there.
